Current financial headlines

Sharemaestro Newsreel

Financial news from across the world, newest first. Choose a country or market group, open the source, or continue into the company data.

Showing
577–612
Headlines
2080
Sources here
17
Companies here
22
Current section United States Medical Care Facilities news

Chronological news

Earlier headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

Kaplan Fox is Investigating The Ensign Group, Inc. (ENSG) for Potential Violations of the Federal Securities Laws

Kaplan Fox & Kilsheimer LLP is investigating The Ensign Group, Inc. (ENSG) for potential securities violations following a Hunterbrook Media report alleging inadequate patient care and data manipulation. The report, titled "Ensign: The Nursing Home Empire Built On Fatal Neglect," caused Ensign's stock to …

ENSG main company
Sharemaestro market context Price below Trend Line 52 weeks +5.5% · Next-week setup positive 63.2% ENSG stored weekly price path from 22 Aug 2025 to 14 Aug 2026

21,400 Shares in The Ensign Group, Inc. $ENSG Bought by Renaissance Technologies LLC

Renaissance Technologies LLC acquired a new stake of 21,400 shares in The Ensign Group, Inc. (ENSG) during the first quarter, valued at approximately $4.3 million. This purchase contributes to the 96.12% institutional ownership of ENSG, although some directors recently sold shares under pre-arranged plans. …

ENSG main company
Sharemaestro market context Price below Trend Line 52 weeks +5.5% · Next-week setup positive 63.2% ENSG stored weekly price path from 22 Aug 2025 to 14 Aug 2026

ENCOMPASS HEALTH CORP : TRUIST SECURITIES RAISES TARGET PRICE TO $150 FROM $140

Truist Securities has increased its target price for Encompass Health Corp (EHC.N) from $140 to $150. This adjustment signals a more optimistic outlook from the financial firm regarding the company's future stock performance.

EHC main company
Sharemaestro market context Trend signal active 52 weeks +4.6% EHC stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Earnings call transcript: Concentra Q2 2026 profit, guidance raise lift shares 11%

Concentra Group Holdings Parent Inc. reported strong Q2 2026 results with a 10% increase in revenue to $606 million and adjusted EPS of $0.52, leading to an 11% surge in shares. The company also raised its full-year 2026 guidance for revenue, adjusted EBITDA, and …

CON main company
Sharemaestro market context Trend signal active 52 weeks +48.2% CON stored weekly price path from 15 Aug 2025 to 7 Aug 2026

DocGo Inc. (NASDAQ:DCGO) Receives Consensus Rating of "Hold" from Analysts

DocGo Inc. (NASDAQ:DCGO) has received a consensus "Hold" rating from six analysts, with an average 12-month price target of $2.375, significantly higher than its recent share price of $0.62. The company exceeded revenue expectations for its latest quarter, reporting $75.55 million against an estimated …

DCGO main company
Sharemaestro market context Price above Trend Line 52 weeks -61.2% DCGO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

agilon health, inc. Stock 12‑Month Price Target Raised to $106.69, Implies 1% Downside

agilon health, inc.'s average stock price target has been raised from $85.92 to $106.69 by 13 analysts, with a range of $31 to $141 per share. This updated target suggests a 1% potential downside based on the August 5th closing price. The consensus rating …

AGL main company
Sharemaestro market context Trend signal active 52 weeks +244.2% · Next-week setup positive 56.0% AGL stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Cross Country Healthcare Inc (CCRN) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Cross Country Healthcare Inc (CCRN), indicating a current earnings forecast score of 6.00 and an average price target of $11.00. It highlights expected revenue of $243.83M for the next quarter and an anticipated EPS of $0.01, following …

CCRN main company
Sharemaestro market context Trend signal active 51 weeks +4.2% · Next-week setup negative 38.9% CCRN stored weekly price path from 8 Aug 2025 to 24 Jul 2026

Concentra Group Holdings Parent, Inc. (CON) Stock Price, News, Quote & History

This Yahoo Finance page provides comprehensive information on Concentra Group Holdings Parent, Inc. (CON) stock, including its current price, historical data, financial overview, and analyst insights. The stock closed at $34.06 on August 7, 2026, up 11.53%, with significant year-to-date and one-year returns. The …

CON main company
Sharemaestro market context Trend signal active 52 weeks +48.2% CON stored weekly price path from 15 Aug 2025 to 7 Aug 2026

DaVita Shares Rise After TD Cowen Upgrades Stock to Buy

DaVita shares rose after TD Cowen upgraded the stock from Hold to Buy and increased its price target to $220. This upgrade was based on DaVita's strengthening competitive position, improving long-term growth prospects, and the potential impact of the MOTheR trial. The upgrade follows …

DVA main company
Sharemaestro market context Trend signal active 52 weeks +35.7% DVA stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Truist Adjusts Price Target on DaVita to $215 From $250, Maintains Hold Rating

Truist has lowered its price target for DaVita (NYSE: DVA) to $215 from $250, while reiterating a "Hold" rating on the stock. This adjustment comes amidst other analyst actions on DaVita, with some firms raising and others adjusting their price targets, and follows DaVita's …

DVA main company
Sharemaestro market context Trend signal active 52 weeks +35.7% DVA stored weekly price path from 15 Aug 2025 to 7 Aug 2026

agilon health, inc. (AGL) stock price, news, quote and history

This page provides comprehensive information on agilon health, inc. (AGL) stock, including its current price, historical data, news, and financial analysis. It details key statistics like market cap, PE ratio, and earnings date, alongside performance comparisons with the S&P 500. The article also includes …

AGL main company
Sharemaestro market context Trend signal active 52 weeks +244.2% · Next-week setup positive 56.0% AGL stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Janus Henderson Group PLC Raises Stock Position in DaVita Inc. $DVA

Janus Henderson Group PLC significantly increased its stake in DaVita Inc. by 96.2% during the first quarter, acquiring an additional 18,237 shares to total 37,188 shares valued at approximately $5.7 million. Other institutional investors also adjusted their positions, with institutional ownership now standing at …

DVA mentioned
Sharemaestro market context Trend signal active 52 weeks +35.7% DVA stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Renaissance Technologies LLC Reduces Stock Position in Compass Pathways PLC Sponsored ADR $CMPS

Renaissance Technologies LLC decreased its stake in Compass Pathways PLC by 10.6% in the first quarter of 2026, selling 102,492 shares but still retaining 865,354 shares valued at $4.8 million. Despite this reduction, other institutional investors increased their positions, and analysts generally maintain a …

CMPS main company
Sharemaestro market context Trend signal active 52 weeks +191.8% CMPS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

COMPASS Pathways (NasdaqGS:CMPS) Stock Forecast & Analyst Predictions

COMPASS Pathways (CMPS) is forecast to grow earnings and revenue significantly, with analysts predicting a 56.4% earnings growth rate and 67.5% revenue growth rate annually. The company's lead asset, COMP360 psilocybin treatment, has shown promising Phase 3 trial results for treatment-resistant depression (TRD) and …

CMPS main company
Sharemaestro market context Trend signal active 52 weeks +191.8% CMPS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Cohen & Steers (PACS) reports 4.67% beneficial stake in PACS Group

Cohen & Steers and its affiliates have reported a beneficial ownership of 4.67% in PACS Group, Inc. common stock, totaling 7,396,136 shares. This filing, a SCHEDULE 13G/A, indicates that their stake is below the 5% threshold typically referenced for significant holders. The various Cohen …

PACS main company
Sharemaestro market context Trend signal active 52 weeks +321.2% PACS stored weekly price path from 15 Aug 2025 to 7 Aug 2026

AMN Healthcare Services Q2 2026 Earnings Call Transcript

AMN Healthcare Services reported Q2 2026 earnings that exceeded expectations, with consolidated revenue up 2% year-over-year to $673 million and adjusted EPS at $0.77. The company saw strong performance in Nurse and Allied Solutions, driven by increased demand and improved fill rates, while Physician …

AMN main company
Sharemaestro market context Trend signal active 52 weeks +90.3% AMN stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Why is DaVita stock up 2% today?

DaVita HealthCare Partners Inc. stock rose 2.1% in pre-open trading today after TD Cowen upgraded the kidney dialysis provider from Hold to Buy, increasing its price target to $220 from $201. Analysts cited an improving market position, new care modality potential from MOTheR trial …

DVA main company
Sharemaestro market context Trend signal active 52 weeks +35.7% DVA stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Guardian Pharmacy Services shares rise 3% on guidance beat

Guardian Pharmacy Services (NYSE:GRDN) reported strong second-quarter results, exceeding analyst expectations for guidance. The company raised its full-year 2026 revenue and adjusted EBITDA guidance, leading to a 3.22% rise in pre-market trading. Despite some impact from IRA-related pricing reductions, the underlying business momentum remained …

GRDN main company
Sharemaestro market context Trend signal active 52 weeks +85.6% GRDN stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Chemed Corp (CHE) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Chemed Corp (CHE), highlighting its current price momentum score of 3.68 and its position within the Healthcare Providers & Services industry. It details the stock's support and resistance levels, and analyzes various technical indicators and moving averages, …

CHE main company
Sharemaestro market context Trend signal active 52 weeks +24.7% CHE stored weekly price path from 15 Aug 2025 to 7 Aug 2026

The Pennant Group, Inc. $PNTG Shares Bought by Sei Investments Co.

Sei Investments Co. increased its stake in The Pennant Group, Inc. (NASDAQ:PNTG) by 33.7% in the first quarter, now holding 153,546 shares valued at $4.68 million. Other institutional investors have also adjusted their positions, with collective institutional ownership reaching 85.88%. The company reported strong …

PNTG main company
Sharemaestro market context Trend signal active 52 weeks +56.2% · Next-week setup positive 57.7% PNTG stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Dimensional Fund Advisors LP Acquires 614,250 Shares of PACS Group, Inc. $PACS

Dimensional Fund Advisors LP significantly increased its stake in PACS Group, Inc. (NYSE:PACS) by 370.2% in the first quarter, purchasing 614,250 additional shares to hold a total of 780,159 shares valued at approximately $25.1 million. Other institutional investors also expanded their positions in PACS …

PACS main company
Sharemaestro market context Trend signal active 52 weeks +321.2% PACS stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Nutex Health Inc. 2026: Revenue $210.75M, EPS $9.38— 10-Q Summary

Nutex Health Inc. reported strong financial results for the 2026 quarter, with revenue reaching $210.75 million and diluted earnings per share at $9.38. This marks a significant improvement from the prior year's net loss. The company saw hospital patient visits increase, and benefited from …

NUTX main company
Sharemaestro market context Trend signal active 52 weeks +102.8% NUTX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Can DaVita’s (DVA) Better Mortality Trends Redefine Its Core Dialysis Investment Story?

DaVita Inc. (DVA) reported strong Q2 2026 results with increased revenue and net income, alongside improved patient mortality and treatment volumes. The company's core dialysis business shows promise, with management reaffirming its 2026 outlook and deploying advanced hemodialysis dialyzers. Despite these clinical gains and …

DVA main company
Sharemaestro market context Trend signal active 52 weeks +35.7% DVA stored weekly price path from 15 Aug 2025 to 7 Aug 2026

NUTEX HEALTH REPORTS SECOND QUARTER 2026 FINANCIAL RESULTS

Nutex Health Inc. announced strong financial results for the second quarter and first six months of 2026, with net income attributable to Nutex Health significantly increasing to $65.8 million and $112.6 million, respectively, compared to losses and smaller gains in the prior year. The …

NUTX main company
Sharemaestro market context Trend signal active 52 weeks +102.8% NUTX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Pennant Group sees ‘steady stream’ of senior living deals in second quarter

The Pennant Group reported a "steady stream" of senior living deals in the second quarter of 2026, including several acquisitions across Arizona, Wisconsin, and California. This growth led to a significant increase in senior living segment revenue and overall company revenue. The company is …

PNTG main company
Sharemaestro market context Trend signal active 52 weeks +56.2% · Next-week setup positive 57.7% PNTG stored weekly price path from 22 Aug 2025 to 14 Aug 2026

1 Healthcare Stock Worth Your Attention and 2 We Ignore

1 Healthcare Stock Worth Your Attention and 2 We Ignore From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Shareholders who bet on the industry have been rewarded lately as healthcare stocks have returned 18.3% over …

ACHC main company
Sharemaestro market context Trend signal active 52 weeks +37.4% ACHC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Earnings call transcript: The Joint tops Q2 2026 estimates as profit improves

The Joint Corp. exceeded Q2 2026 earnings and revenue estimates, reporting adjusted EPS of $0.05 and revenue of $15.2 million, driven by its shift towards a capital-light franchising model. The company saw a significant improvement in profitability, with adjusted EBITDA from continuing operations rising …

JYNT main company
Sharemaestro market context Price below Trend Line 52 weeks -20.4% JYNT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Healthcare Services Group Inc (HCSG) Earnings Forecast: Future EPS & Revenue Growth Estimates

Healthcare Services Group Inc (HCSG) has an earnings forecast score of 7.33, ranking 93rd in its industry, with an average analyst price target of $21.00. Analysts largely recommend a "Buy" for HCSG, projecting an upside of over 21%. The company's expected revenue for the …

HCSG main company
Sharemaestro market context Trend signal active 52 weeks +36.9% HCSG stored weekly price path from 22 Aug 2025 to 14 Aug 2026

ETFs Investing in COMPASS Pathways Plc Sponsored ADR Stocks

This article lists various ETFs that hold COMPASS Pathways Plc Sponsored ADR stocks, providing details such as market value, weight, issuer, management style, expense ratio, AUM, price, and performance metrics. The list is sorted by market value and aims to make investing in these …

CMPS main company
Sharemaestro market context Trend signal active 52 weeks +191.8% CMPS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Is Guardian Pharmacy (GRDN) Using Tech-Driven Kentucky Expansion to Redefine Its Long-Term Care Edge?

Guardian Pharmacy Services has expanded its presence into Kentucky with a new technology-driven long-term care pharmacy in Lexington, aimed at serving various care settings. This expansion is part of Guardian's strategy to scale its tech-enabled pharmacy network, with the company reaffirming its 2026 revenue …

GRDN main company
Sharemaestro market context Trend signal active 52 weeks +85.6% GRDN stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context